RE:RE:RE:Sermonizer VS WhinersssssssssssssssssssssThat's why it would be beneficial if they had started the NASH phase 3 early in case the oncology results are not good, in fact the way I see it the possibility of getting NASH approved atm is higher as they have the dosing and safety and efficacy with or without holes.
Wino115 wrote: that's the risk with all drug developments. I like the fact our toxin is known and it's heavily about the target effectiveness and other aspects. No doubt it's hard. But I like we have 4 shots on goal in cancer, 2 in NASH if we include HIV, 2 shots to get revenues up and 1 shot with a new Egifta formula and Trogarzo Push. That's a lot of shots on goal even though some face similar development risks. They should talk that way in their presentation. It was the highlight slide for the Texas company Bucknelly posted this morning.
scarlet1967 wrote: And what if oncology hit the brick wall, although no value has been ascribed to the program as mentioned earlier the stock hasn't had any problem reacting to bad news therefore I would be more comparable if the SP was much higher during that trial.Some might don't mind loosing money or not making money during a bull market well I absolutely DO.
palinc2000 wrote: but at least we now know that if phase 3 trials are successful in Nash and oncology the SP will go to the moon,
I feel much better now,,,,
Disclosure
I am long this stock and have no relation whatsoever with anyone working at TH past or present